Dual targeting of PD-1/PD-L1 and iL-33/ST2 signalling pathways: a promising approach in breast cancer immunotherapy
Introduction The immune checkpoint axis PD-1/PD-L1 is a cornerstone of cancer immunotherapy. However, its efficacy in breast cancer is often limited by a complex and immunosuppressive tumour microenvironment (TME). The IL-33/ST2 signalling pathway, a key player in type 2 inflammation, is increasingl...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2025-12-01
|
| coleção: | Annals of Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2593198 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|